First Tracks Biotherapeutics Inc
- TRAX
- NASDAQ
- Biotechnology
- Immunology/Autoimmune
- Antibody Therapeutics
$36.28
Today +5.28%Quote Oct 19, 2026, 08:00 PM UTC
−6.01%over the last month
Max drawdown −25.4%From 1-month high −11.6%3 months −2.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About First Tracks Biotherapeutics
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
104
Market value
$1.30B
Quote Oct 19
Floor
$35.28
2.8% below price
Resistance
$39.68
9.4% above price
Price vs analyst targets
8 analysts
Lowest target
$46.00Highest target
$100.00
$46.00Highest target
$100.00
- Price $36.28
- Average target $68.80
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 90% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TRAXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free